🇺🇸 FDA
Patent

US 6525062

Method of treating pain using nalbuphine and opioid antagonists

expired A61KA61K31/485A61P

Quick answer

US patent 6525062 (Method of treating pain using nalbuphine and opioid antagonists) held by The Regents of the University of California expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
97
CPC classes
A61K, A61K31/485, A61P, A61P25/02, A61P25/04